SOAT1 and scleroderma: Considering the effects of JAK/STAT pathway in the pathogenesis of inflammation and fibrosis, our study aimed to determine the effects of TOFA and MET treatments that inhibit the JAK/STAT pathway on IL-17 and TGF-β cytokines, skin fibrosis and inflammation by creating an experimental scleroderma model.